AgenoW,GallusAS,WittkowskyA,CrowtherM,HylekEM,PalaretiG, 2012.American College of Chest Physicians evidence-based clinical practice guidelines,Chest 141 e44S -e88S
ConnollySJ,PogueJ,EikelboomJ,FlakerG,CommerfordP,FranzosiMG, .Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range, 35 146 -
WallentinL,YusufS,EzekowitzMD,AlingsM,FlatherM,FranzosiMG, .Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial,Lancet. 2010 Sep 376 975 -83
SingerDE,HellkampAS,PicciniJP,MahaffeyKW,LokhnyginaY,PanG, .Impact of Global Geographic Region on Time in Therapeutic Range on Warfarin Anticoagulant Therapy: Data From the ROCKET AF Clinical Trial,2013 Feb 19 e000067 -e000067
BastakotiS,KhanalS,DahalB,PunNT, 2013.Adherence and nonadherence to treatments: focus on pharmacy practice in Nepal,J Clin Diagn Res 7 754 -7
AhmedW,AsifR,KhanUM, 2007.Compliance, frequency of target INR achievement and complications in patients on long term oral anticoagulant therapy,Pak J Cardiol 18 7 -11
FarooqF,MujtabaSF, 2012.Frequency of achieving target INR in patients with prosthetic heart valves,Pakistan Heart J 45 121 -5
RosendaalFR,CannegieterSC,van der MeerFJ,BriëtE., 1993.A method to determine the optimal intensity of oral anticoagulant therapy,Thromb Haemost 69 236 -9
RoseAJ,MillerDR,OzonoffA,BerlowitzDR,AshAS,ZhaoS, 2013.Gaps in monitoring during oral anticoagulation: insights into care transitions, monitoring barriers, and medication nonadherence,CHEST 143 751 -7
BangOY,HongKS,HeoJH,KooJ,KwonSU,YuKH, 2014.New oral anticoagulants may be particularly useful for Asian stroke patients,J Stroke 16 73 -80
ErikssonN,WadeliusM., 2012.Prediction of warfarin dose: why, when and how?,Pharmacogenomics 13 429 -40
DlottJS,GeorgeRA,HuangX,OdehM,KaufmanHW,AnsellJ, 2014.A national assessment of warfarin anticoagulation therapy for stroke prevention in atrial fibrillation,Circulation 129 1407 -14
MillerCS,GrandiSM,ShimonyA,FilionKB,Eisenberg MJ, 2012.Metaanalysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation,Am J Cardiol 110 453 -60
KhanM,WasayM, 2016.New Oral Anticoagulants: Need and Challenges in a Developing Country,J Coll Physicians Surg Pak 26 551 -2
Wigle P, Hein B, Bloomfield HE, Tubb M, Doherty M. Updated
guidelines on outpatient anticoagulation. Am Fam Physician.
2013 Apr 15;87(8):556-66. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/23668445.
Rose AJ, Berlowitz DR, Frayne SM, Hylek EM. Measuring
quality of oral anticoagulation care: Extending quality
measurement to a new field. Jt Comm J Qual Patient Saf.
2009 Mar;35(3):146-55